TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18953578

Group type: EXPERIMENTAL
Intervention: Physical Training (PT)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Physical Training plus Cognitive-Behavioral Therapy (PT + CBT)
Number of subjects: 147
Study: 16972160

Group type: EXPERIMENTAL
Intervention: EQ-5D Index score
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: EQ-5D Index and Visual Analogue scores
Number of subjects: 221

Group type: COMPARATOR
Intervention: EQ-5D scores
Number of subjects: 221
Study: 15804802

Group type: EXPERIMENTAL
Intervention: Aspirin 160 mg/d
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg/d
Number of subjects: 1000
Study: 11190013

Group type: EXPERIMENTAL
Intervention: diclofenac 0.1% ophthalmic solution
Number of subjects: 120

Group type: COMPARATOR
Intervention: ketorolac 0.5% ophthalmic solution
Number of subjects: 120
Study: 10073029

Group type: EXPERIMENTAL
Intervention: Improved passing peritoneum extraperitoneal cesarean section
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Extraperitoneal cesarean section
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Low segment cesarean section
Number of subjects: 150

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 150
Study: 8104727

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg.kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vecuronium 0.08 mg.kg‐1
Number of subjects: 0
Study: 2947953

Group type: EXPERIMENTAL
Intervention: 5 micrograms hepatitis B vaccine
Number of subjects: 662

Group type: COMPARATOR
Intervention: 10 micrograms hepatitis B vaccine
Number of subjects: 662
Study: 29463591

Group type: EXPERIMENTAL
Intervention: Lifestyle Advice Group (dietary and lifestyle advice through three face-to-face sessions and three telephone calls)
Number of subjects: 624

Group type: COMPARATOR
Intervention: Standard Care Group (routine antenatal care)
Number of subjects: 624
Study: 26821959

Group type: EXPERIMENTAL
Intervention: Triple-loaded single-row repair augmented with platelet-rich plasma fibrin membrane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Suture-bridging double-row repair augmented with platelet-rich plasma fibrin membrane
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both interventions (triple-loaded single-row and suture-bridging double-row)
Number of subjects: 40
Study: 24927068

Group type: EXPERIMENTAL
Intervention: Topical agent (Skinceuticals Body Tightening Concentrate) applied twice daily to one designated thigh/buttock
Number of subjects: 20

Group type: COMPARATOR
Intervention: Radiofrequency (RF) device (Alma Accent) treatment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical agent (Skinceuticals Body Tightening Concentrate)
Number of subjects: 20
Study: 22345330

Group type: EXPERIMENTAL
Intervention: Milk-based cornstarch porridge fortified with 10 mg elemental iron (FeSO4), daily, during 14 weeks
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 131
Study: 20079569

Group type: EXPERIMENTAL
Intervention: Slow breathing
Number of subjects: 52

Group type: COMPARATOR
Intervention: Normal breathing
Number of subjects: 52
Study: 18755342

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) or enoxaparin plus a glycoprotein (GP) IIb/IIIa inhibitor
Number of subjects: 7789

Group type: EXPERIMENTAL
Intervention: Bivalirudin plus a GP IIb/IIIa inhibitor
Number of subjects: 7789

Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 7789
Study: 16381363

Group type: EXPERIMENTAL
Intervention: 5-point laparoscopic ovarian electrocauterization
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: 10-point laparoscopic ovarian electrocauterization
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: 15-point laparoscopic ovarian electrocauterization
Number of subjects: 187
Study: 12063455

Group type: EXPERIMENTAL
Intervention: Normothermic systemic perfusion (37 degrees C)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Hypothermic systemic perfusion (26 degrees C)
Number of subjects: 113
Study: 10102851

Group type: EXPERIMENTAL
Intervention: Nursing intervention for breathlessness (breathing control, activity pacing, relaxation techniques, psychosocial support)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Best supportive care (standard management and treatment for breathlessness, breathing assessments)
Number of subjects: 119
Study: 8582466

Group type: COMPARATOR
Intervention: HFA-Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: CFC-Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: HFA-Salbutamol
Number of subjects: 12
Study: 2236367

Group type: EXPERIMENTAL
Intervention: Conventional pulsating fluorescent light
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional fluorescent light
Number of subjects: 48

Group type: COMPARATOR
Intervention: Steady fluorescent light
Number of subjects: 48

Group type: COMPARATOR
Intervention: Incandescent light
Number of subjects: 48
Study: 568293

Group type: EXPERIMENTAL
Intervention: Paracetamol (N-acetyl-p-amino-phenol)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30183710

Group type: EXPERIMENTAL
Intervention: Internet-based stress management program ('I'm managing my stress'), composed of four sessions based on cognitive-behavioral therapy.
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 128
Study: 27732819

Group type: EXPERIMENTAL
Intervention: Current standard of care plus ZMapp (50 mg/kg, administered every third day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Current standard of care alone
Number of subjects: 72
Study: 24768960

Group type: EXPERIMENTAL
Intervention: Excision
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ablation
Number of subjects: 0
Study: 22279232

Group type: EXPERIMENTAL
Intervention: Nociceptive stimulus applied after presentation of neutral scenes
Number of subjects: 0
Study: 19634167

Group type: EXPERIMENTAL
Intervention: Trospium chloride XR
Number of subjects: 1165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1165
Study: 18622147

Group type: EXPERIMENTAL
Intervention: peg‐interferon plus ribavirin combined therapy
Number of subjects: 44
Study: 16026361

Group type: EXPERIMENTAL
Intervention: Pioglitazone (30‐45 mg/day, n = 38)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Metformin (750 mg/day, n = 39)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Glimepiride (1.0‐2.0 mg/day, n = 37)
Number of subjects: 114
Study: 12361442

Group type: EXPERIMENTAL
Intervention: CHILD Profile
Number of subjects: 2472

Group type: EXPERIMENTAL
Intervention: Other computerized systems
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Family physicians
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Private physicians
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Physicians taking fewest opportunities to immunize
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Physicians in areas with CHILD Profile marketing activity
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Physicians in areas with little or no registry activity
Number of subjects: 2472

Group type: EXPERIMENTAL
Intervention: Physicians with computerized systems
Number of subjects: 2472

Group type: COMPARATOR
Intervention: Physicians without computerized systems
Number of subjects: 2472
Study: 10408844

Group type: EXPERIMENTAL
Intervention: Epoetin alpha 300 IU kg(‐1) subcutaneously three times a week
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Epoetin alpha 150 IU kg(‐1) subcutaneously three times a week
Number of subjects: 130

Group type: COMPARATOR
Intervention: No additional treatment (control group)
Number of subjects: 130
Study: 8543404

Group type: EXPERIMENTAL
Intervention: 3 mg/m2 AS101 combined with carboplatin and VP-16
Number of subjects: 58

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 58
Study: 2056971

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 646

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: IT MTX plus cranial radiation
Number of subjects: 646

Group type: COMPARATOR
Intervention: IT MTX alone
Number of subjects: 646
Study: 6847362

Group type: EXPERIMENTAL
Intervention: Gastric exclusion (bypass)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Gastric partition (gastroplasty)
Number of subjects: 100
Study: 31475791

Group type: EXPERIMENTAL
Intervention: Drainage ball with low negative pressure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chest tube with water‐sealed bottle
Number of subjects: 60
Study: 29049180

Group type: EXPERIMENTAL
Intervention: Care intervention (dietary, exercise, and psychology interventions on the basis of conventional care)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 126
Study: 25256627

Group type: EXPERIMENTAL
Intervention: Adaptive working memory (WM) training
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Adaptive cognitive flexibility-training
Number of subjects: 121

Group type: COMPARATOR
Intervention: Non-adaptive control training (mock-training)
Number of subjects: 121
Study: 24968008

Group type: EXPERIMENTAL
Intervention: Right rTMS
Number of subjects: 48

Group type: COMPARATOR
Intervention: Left rTMS
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 48
Study: 22172646

Group type: EXPERIMENTAL
Intervention: Letrozole (LET) for 2.5 years
Number of subjects: 1215

Group type: COMPARATOR
Intervention: Letrozole (LET) for 5 years
Number of subjects: 1215

Group type: EXPERIMENTAL
Intervention: Letrozole (LET)
Number of subjects: 1215
Study: 19168237

Group type: EXPERIMENTAL
Intervention: ADMA plasma levels measured by high-performance liquid chromatography
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of acetylcholine (ACh)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Homeostasis model assessment (HOMA)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: ADMA and gender
Number of subjects: 84
Study: 17571296

Group type: EXPERIMENTAL
Intervention: Preoperative intraperitoneal local anaesthesia (50 ml 0.5 per cent lidocaine)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Postoperative intraperitoneal local anaesthesia (50 ml 0.5 per cent lidocaine)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo solution (50 ml 0.9 per cent saline)
Number of subjects: 133
Study: 16135164

Group type: EXPERIMENTAL
Intervention: 1 mg terbutaline
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1 mg terbutaline after withdrawal from beta(2) agonists
Number of subjects: 16
Study: 11814533

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 10411700

Group type: EXPERIMENTAL
Intervention: Normal hematocrit (42 +/- 3%)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Anemic hematocrit (30 +/- 3%)
Number of subjects: 28
Study: 7550179

Group type: EXPERIMENTAL
Intervention: Rifabutin 300 mg/day
Number of subjects: 1104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1104
Study: 2029659

Group type: EXPERIMENTAL
Intervention: Vitamin E (2000 IU 12 hours prior to surgery) and Vitamin C (2 g on the day of operation)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vitamin E and Vitamin C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no vitamin E or C treatment)
Number of subjects: 20
Study: 6135725

Group type: EXPERIMENTAL
Intervention: Low dose propranolol (22 +/- 4 mg four times daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 12
Study: 31573893

Group type: EXPERIMENTAL
Intervention: Sofosbuvir 400 mg/Daclatasvir 60 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sofosbuvir 400 mg/Ledipasvir 90 mg
Number of subjects: 100
Study: 30942258

Group type: EXPERIMENTAL
Intervention: Miltefosine 1.3‐2 mg/kg/day for 28 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Meglumine antimoniate (N‐MA) 20 mg SbV/kg/day for 30 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Miltefosine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Meglumine antimoniate (N‐MA)
Number of subjects: 40
Study: 28872914

Group type: EXPERIMENTAL
Intervention: Edaravone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27194863

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.12% (CHX) preprocedural rinse
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High volume evacuator (HVE)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of CHX (0.12%) and HVE
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ultrasonic scaling without intervention (Control Group A)
Number of subjects: 45
Study: 24637126

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg/day
Number of subjects: 876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 876
Study: 19463332

Group type: EXPERIMENTAL
Intervention: Conservative medical management
Number of subjects: 8225

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 8225

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 8225
Study: 15150185

Group type: EXPERIMENTAL
Intervention: Ertapenem 1 g once a day
Number of subjects: 850

Group type: COMPARATOR
Intervention: Ceftriaxone 1 g once a day
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Ertapenem and Ceftriaxone
Number of subjects: 850
Study: 11030869

Group type: EXPERIMENTAL
Intervention: Surgical trauma under general anesthesia
Number of subjects: 15
Study: 9302369

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) administration
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo treatment for the first 6 months followed by GH administration for the next 6 months
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: GH administration
Number of subjects: 46
Study: 8287572

Group type: EXPERIMENTAL
Intervention: Suramin i.v. (for haemolymphatic sleeping sickness)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Melarsoprol (for cerebral sleeping sickness)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Suramin i.v. / Melarsoprol (during treatment)
Number of subjects: 65
Study: 2882736

Group type: COMPARATOR
Intervention: Imipramine hydrochloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vivo exposure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Office-based behavioral therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vivo exposure without imipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vivo exposure with imipramine
Number of subjects: 0
Study: 30801744

Group type: EXPERIMENTAL
Intervention: Individualized gonadotropin dosing based on AMH levels
Number of subjects: 1326
Study: 28433473

Group type: EXPERIMENTAL
Intervention: HIGH resistance training (8 males, 10 females, 2 × 10–15 repetitions at 80% 1RM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: LOW resistance training (9 males, 10 females, 1 × 80–100 repetitions at 20% 1RM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: LOW+ resistance training (9 males, 10 females, 1 × 60 repetitions at 20% 1RM followed by 1 × 10–20 repetitions at 40% 1RM)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All groups post-exercise
Number of subjects: 56
Study: 28031039

Group type: EXPERIMENTAL
Intervention: Attention training using novel eye‐tracking technology and gaze‐contingent training paradigms, nine weekly home‐based sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non‐gaze‐contingent age‐appropriate videos, nine weekly home visits
Number of subjects: 50
Study: 24433822

Group type: EXPERIMENTAL
Intervention: FAST parent programme (First‐aid Advice and Safety Training)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (normal care)
Number of subjects: 96
Study: 22487033

Group type: EXPERIMENTAL
Intervention: Reinforcement Learning (RL) with integrated Working Memory (WM) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: COMT gene influence on WM capacity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPR6 gene influence on RL learning rate
Number of subjects: 0
Study: 19038848

Group type: EXPERIMENTAL
Intervention: atorvastatin (10 mg/d) for 6 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: torcetrapib/atorvastatin (60/10 mg/d) for 6 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control subjects (healthy controls)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CETP inhibition
Number of subjects: 25
Study: 17503980

Group type: EXPERIMENTAL
Intervention: Sertraline (25‐200 mg/day)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 15550799

Group type: EXPERIMENTAL
Intervention: PHQ-9
Number of subjects: 434
Study: 11136908

Group type: EXPERIMENTAL
Intervention: CADASIL individuals
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nondisabled CADASIL individuals (Rankin=0, n=21)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Disabled CADASIL individuals
Number of subjects: 29
Study: 9812660

Group type: EXPERIMENTAL
Intervention: Colonic dialysis therapy with Chinese herbal medicine (from third day to eighth day)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Combined dihydroetorphine (DHE) and methadon therapy
Number of subjects: 125
Study: 8588492

Group type: EXPERIMENTAL
Intervention: Periconceptional multivitamin supplementation (including 0.8 mg folic acid)
Number of subjects: 5502

Group type: COMPARATOR
Intervention: Placebo-like trace-element control group
Number of subjects: 5502
Study: 3662586

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 200 micrograms twice daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 200 micrograms twice daily
Number of subjects: 10
Study: 28892558

Group type: EXPERIMENTAL
Intervention: 18 mg of selonsertib orally once daily for 24 weeks
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 6 mg of selonsertib orally once daily for 24 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Simtuzumab alone
Number of subjects: 72
Study: 26909323

Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24699924

Group type: EXPERIMENTAL
Intervention: Modified mini-Hardinge approach
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard approach
Number of subjects: 51
Study: 22644776

Group type: EXPERIMENTAL
Intervention: Cetuximab plus capecitabine/irinotecan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cetuximab plus capecitabine/oxaliplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetuximab (first-cycle rash observed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No Cet-ST
Number of subjects: 0
Study: 20494665

Group type: EXPERIMENTAL
Intervention: Folic acid, vitamin B(12), and vitamin B(6)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Folic acid/vitamin B(12)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Vitamin B(6)
Number of subjects: 348
Study: 19020693

Group type: EXPERIMENTAL
Intervention: Very early mobilization (within 24 hours of stroke)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 71
Study: 17089238

Group type: EXPERIMENTAL
Intervention: Multidisciplinary care (MDC)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine care (RC)
Number of subjects: 160
Study: 14616453

Group type: EXPERIMENTAL
Intervention: High-energy transurethral microwave thermotherapy (HE-TUMT)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 144
Study: 10649829

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg SQ)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 8629587

Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pravastatin 40 mg/day
Number of subjects: 0
Study: 1424176

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA, 50 mg once daily from Day 5 to Day 15) and ethinyl oestradiol (EE2, 30 micrograms once daily from Day 5 to Day 24 of the menstrual cycle)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 40
Study: 4096742

Group type: EXPERIMENTAL
Intervention: Normal-release 10 mg nifedipine soft gelatine capsule (Pidilat)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Marketed product (control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 12
Study: 30836964

Group type: EXPERIMENTAL
Intervention: Community health worker (CHW) intervention
Number of subjects: 268

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 268
Study: 30219466

Group type: EXPERIMENTAL
Intervention: Guided imagery (six times a week for four weeks)
Number of subjects: 70
Study: 26751635

Group type: EXPERIMENTAL
Intervention: Intrathecal (IT) and intramuscular (IM) administration of autologous MSC‐NTF cells
Number of subjects: 26
Study: 25222490

Group type: EXPERIMENTAL
Intervention: Processed hamburger meat meal (M-meal)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vegan meal (V-meal)
Number of subjects: 100
Study: 21856047

Group type: EXPERIMENTAL
Intervention: Leisure activity (high levels)
Number of subjects: 4303

Group type: EXPERIMENTAL
Intervention: Leisure activity (low levels)
Number of subjects: 4303

Group type: EXPERIMENTAL
Intervention: APOE ε4 carriers
Number of subjects: 4303

Group type: EXPERIMENTAL
Intervention: APOE ε4 noncarriers
Number of subjects: 4303

Group type: EXPERIMENTAL
Intervention: APOE ε4 carriers and noncarriers (after adjustment for demographic and health factors)
Number of subjects: 4303
Study: 20219584

Group type: EXPERIMENTAL
Intervention: GaAlAs laser therapy (P = 100 mW, lambda = 830 nm, Ø = 0.06 cm(2), applied in 8 sessions with intervals of 48 hours)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 13
Study: 17676201

Group type: EXPERIMENTAL
Intervention: Midazolam (0.02 mg kg‐1) + Propofol (0.2 mg kg‐1) + Fentanyl (1 microgram kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Midazolam (0.02 mg kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Midazolam (0.02 mg kg‐1) + Propofol (0.2 mg kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Midazolam (0.02 mg kg‐1) + Fentanyl (1 microgram kg‐1)
Number of subjects: 0
Study: 15789787

Group type: EXPERIMENTAL
Intervention: Same admission colostomy closure (SACC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional delayed colostomy closure (CDCC)
Number of subjects: 60